Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 21;31(4):358-362.
doi: 10.1136/ejhpharm-2022-003604.

Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags

Affiliations

Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags

Roland B van den Berg et al. Eur J Hosp Pharm. .

Abstract

Objectives: The closure integrity and process validation of closed system transfer devices (CSTDs) should be confirmed before implementation in clinical settings. We aimed to investigate the closure integrity and validate the aseptic procedure of two types of CSTDs by using a combination of the dye ingress test and a media fill test.

Methods: The dye ingress test with methylene blue was used for both CSTDs with 10 samples of drug vials of three brands. A media fill test was performed with both CSTDs (300 samples per CSTD, 150 carried out in a safety cabinet and 150 under non-classified environmental conditions).

Results: In all samples of both CSTDs, methylene blue was absent after visual inspection and spectrophotometric analysis. The nutrient media of one sample with CSTD A and none of the CSTD B samples were contaminated when reconstituted in a GMP grade A environment. Under non-classified environmental conditions, one sample of CSTD A and two samples of CSTD B were contaminated.

Conclusions: Both CSTDs connected to the drug vials met the terms of closure integrity by using the dye ingress test. The aseptic procedure of CSTD B was validated with the media fill test when reconstituted in a GMP grade A environment, but failed for CSTD A. Both CSTDs failed the media fill test when reconstituted under non-classified environmental conditions.

Keywords: chemical safety; drug incompatibility; pharmaceutical preparations; pharmacopoeia; safety.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Connected closed system transfer device (CSTD) A (left) and CSTD B (right).

Similar articles

References

    1. Vossen MG, Milacek C, Thalhammer F. Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis. ESMO Open 2018;3:e000348. 10.1136/esmoopen-2018-000348 - DOI - PMC - PubMed
    1. Pfizer . Summary of product characteristics meronem i.v. 500 mg, powder for solution for injection or infusion. 2019. Available: https://www.cbg-meb.nl [Accessed 21 Jan 2023].
    1. Manning L, Wright C, Ingram PR, et al. Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability. PLoS One 2014;9:e102023. 10.1371/journal.pone.0102023 - DOI - PMC - PubMed
    1. Patel PR, Cook SE. Stability of meropenem in intravenous solutions. Am J Health-Syst Pharm 1997;54:412–21. 10.1093/ajhp/54.4.412 - DOI - PubMed
    1. Franceschi L, Cojutti P, Baraldo M, et al. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures. Ther Drug Monit 2014;36:674–6. 10.1097/FTD.0000000000000054 - DOI - PubMed

Publication types

LinkOut - more resources